KidneyX

DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression

  • by

What You Should Know: – RenalytixAI and DaVita announce a program partnership that aims to slow kidney disease progression and improve outcomes for the nation’s estimated 37 million adults with chronic kidney disease (CKD). – This is the first clinical-grade program that delivers advanced early-stage… Read More »DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression